GT Biopharma, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2015 | 28.88B |
| FY2016 | 29.46B |
| FY2017 | 20.22B |
| FY2018 | 60.6M |
| FY2019 | 60.9M |
| FY2020 | 78.9M |
| FY2021 | 84.5M |
| FY2022 | 3.2M |
| FY2023 | 4.0M |
| FY2024 | 5.7M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2015 | 28.88B |
| FY2016 | 29.46B |
| FY2017 | 20.22B |
| FY2018 | 60.6M |
| FY2019 | 60.9M |
| FY2020 | 78.9M |
| FY2021 | 84.5M |
| FY2022 | 3.2M |
| FY2023 | 4.0M |
| FY2024 | 5.7M |